What Is IGF-1 LR3?

Native IGF-1 is a hormone the liver produces in response to growth hormone signaling, and it mediates much of growth hormone's downstream effect on cell growth, protein synthesis, and metabolism. In its natural form, however, IGF-1 binds tightly to circulating binding proteins, which limits how long it stays active — a limitation that makes native IGF-1 difficult to work with in extended laboratory studies.

IGF-1 LR3 was engineered specifically to address that limitation: the added 13-amino-acid sequence and Arg3 substitution reduce its affinity for IGF-binding proteins, extending its functional activity window considerably compared to unmodified IGF-1. This is why it appears in research literature studying IGF-1 receptor signaling, cell proliferation, and metabolic pathways — its extended activity makes prolonged-exposure experiments more practical than native IGF-1 allows.

IGF-1 LR3 is not approved as a human or veterinary therapeutic anywhere, including the UAE. Where it circulates, it does so as an unregulated research chemical intended strictly for laboratory study — this page describes that research context only and makes no health, performance, or therapeutic claim.